Michael Fehlings is the founder of ImmunoScape. ImmunoScape has raised $39M in total funding. Latest round: Series B. Based in Singapore.
Michael Fehlings is the Chief Executive Officer at ImmunoScape. ImmunoScape is a global spin-off from Singapore's A*STAR, backed by local and international investors. The company's focus and what it does is not detailed in the provided text, nor is its funding history or Fehlings' prior background.
Full founder directory · Investor directory · Company funding database · Fundraising library